SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Magnusson Peetra U.)
 

Sökning: WFRF:(Magnusson Peetra U.) > (2010-2014) > CAR/FoxP3-engineere...

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery

Fransson, Moa (författare)
Uppsala universitet,Klinisk immunologi,Science for Life Laboratory, SciLifeLab
Piras, Elena (författare)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap
Burman, Joachim (författare)
Uppsala universitet,Neurologi
visa fler...
Nilsson, Berith (författare)
Uppsala universitet,Klinisk immunologi,Science for Life Laboratory, SciLifeLab
Essand, Magnus (författare)
Uppsala universitet,Klinisk immunologi,Science for Life Laboratory, SciLifeLab
Lu, Binfeng (författare)
Harris, Robert A (författare)
Karolinska Institutet
Magnusson, Peetra U (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Klinisk immunologi
Brittebo, Eva (författare)
Uppsala universitet,Institutionen för farmaceutisk biovetenskap
Loskog, Angelica Si (författare)
Uppsala universitet,Science for Life Laboratory, SciLifeLab,Klinisk immunologi
visa färre...
 (creator_code:org_t)
2012-05-30
2012
Engelska.
Ingår i: Journal of Neuroinflammation. - : Springer Science and Business Media LLC. - 1742-2094. ; 9, s. 112-
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • BACKGROUND:Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS). In the murine experimental autoimmune encephalomyelitis (EAE) model of MS, T regulatory (Treg) cell therapy has proved to be beneficial, but generation of stable CNS-targeting Tregs needs further development. Here, we propose gene engineering to achieve CNS-targeting Tregs from naive CD4 cells and demonstrate their efficacy in the EAE model.METHODSCD4+T cells were modified utilizing a lentiviral vector system to express a chimeric antigen receptor (CAR) targeting myelin oligodendrocyte glycoprotein (MOG) in trans with the murine FoxP3 gene that drives Treg differentiation. The cells were evaluated in vitro for suppressive capacity and in C57BL/6 mice to treat EAE. Cells were administered by intranasal (i.n.) cell delivery.RESULTSThe engineered Tregs demonstrated suppressive capacity in vitro and could efficiently access various regions in the brain via i.n cell delivery. Clinical score 3 EAE mice were treated and the engineered Tregs suppressed ongoing encephalomyelitis as demonstrated by reduced disease symptoms as well as decreased IL-12 and IFNgamma mRNAs in brain tissue. Immunohistochemical markers for myelination (MBP) and reactive astrogliosis (GFAP) confirmed recovery in mice treated with engineered Tregs compared to controls. Symptomfree mice were echallenged with a second EAE-inducing inoculum but remained healthy, demonstrating the sustained effect of engineered Tregs.CONCLUSIONCNS-targeting Tregs delivered i.n. localized to the CNS and efficiently suppressed ongoing inflammation leading to diminished disease symptoms.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Nyckelord

MS
redirected cells
T regulatory cells
EAE
FoxP3
myelin oligodendrocyte glycoprotein
Neurology
Neurologi

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy